Regulation Identification Number 0910-AJ05 Medical Devices; Laboratory Developed Tests; Implementation of Vacatur
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Sept. 19, 2025. Document 2025-18239. Updated Nov. 19, 2026.
- What it does
On May 6, 2024, the Food and Drug Administration (FDA, the Agency, or we) issued a final rule amending the definition of "in vitro diagnostic products" in FDA's regulations. On March 31, 2025, a federal district court vacated that rule. This final rule reverts to the text of the regulation as it existed prior to the effective date of the May 2024 final rule.
The Food and Drug Administration's summary, as published in the Federal Register.
- What changed in the regulation
1 part of Title 21 of the Code of Federal Regulations:
Wording on eCFR: the day before it took effect and from the day it took effect (first part listed).
- Compared with
The Food and Drug Administration has published 103 final rules in 2026 so far, compared with 68 in all of 2025.
Counted by the Tribune from Federal Register records since Jan. 1, 2025.
- What happens next and when
This rule is effective September 19, 2025.
The agency's dates, word for word.
The record as published
| Document number | 2025-18239 |
|---|---|
| Action | Final rule. |
| Agencies | Health and Human Services Department; Food and Drug Administration |
| Published | Sept. 19, 2025 |
| Effective date | Sept. 19, 2025 |
| Docket | FDA-2025-N-1730 |
Source: the Federal Register (public domain). The document in the Federal Register